カテゴリー： FactMR, 世界, 医療/バイオ

ペプチドベース心臓血管治療薬の世界市場2023年-2033年：予測・動向・分析・競争状況

◆英語タイトル：Peptide-based Cardiovascular Therapeutics Market By Drug (Bivalirudin, Eptifibatide), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Region – Global Market Insights 2023 to 2033

FactMRが発行した調査報告書（FACT23MA040）◆商品コード：FACT23MA040
◆発行会社（リサーチ会社）：FactMR
◆発行日：2023年4月12日
◆ページ数：約170
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Site License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Fact.MR社の本市場調査資料では、世界のペプチドベース心臓血管治療薬市場を徹底的に調査・分析し、予測期間中（2023年〜2033年）の動向を展望しています。本書は、エグゼクティブサマリー、市場概要、治療薬別（ビバリルジン、エプチフィバチド）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、中南米、ヨーロッパ、日本、アジア太平洋、中東・アフリカ）分析、競争状況・企業情報、調査手法、一次情報源・二次情報源、仮定など、以下の構成でまとめています。なお、主な市場参入企業として、AstraZeneca plc、CordenPharma International、Ipsen S.Aなどの情報を含んでいます。
・エグゼクティブサマリー
・市場概要
・世界のペプチドベース心臓血管治療薬市場規模：治療薬別
- ビバリルジンの市場規模
- エプチフィバチドの市場規模
・世界のペプチドベース心臓血管治療薬市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- オンライン薬局チャネルの市場規模
・世界のペプチドベース心臓血管治療薬市場規模：地域別
- 北米のペプチドベース心臓血管治療薬市場規模
- 中南米のペプチドベース心臓血管治療薬市場規模
- ヨーロッパのペプチドベース心臓血管治療薬市場規模
- 日本のペプチドベース心臓血管治療薬市場規模
- アジア太平洋のペプチドベース心臓血管治療薬市場規模
- 中東・アフリカのペプチドベース心臓血管治療薬市場規模
・競争状況・企業情報
・調査手法
・一次情報源・二次情報源
・仮定

本資料には、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報を含んでいます。企業のプレゼンスは、すべての主要プレーヤーについてマッピングされ、マトリックスを通して提供されます。これにより、読者に実用的な洞察を提示し、熟考して市場の状況を提供し、ペプチドベース心臓血管治療薬における競争レベルを推測するのに役立ちます。

PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS Market – Scope of Report

A recent study by Fact.MR on the PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering Peptide-based Cardiovascular Therapeutics.
The study also provides the dynamics responsible for influencing the future status of the PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).
Estimates at global and regional levels for PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.
Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS market during the forecast period.
Country-specific valuation on demand for PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of XYZ, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the PEPTIDE-BASED CARDIOVASCULAR THERAPEUTICS domain.

❖ レポートの目次 ❖

1. Global Market – Executive Summary

2. Global Market Overview

    2.1. Introduction

        2.1.1. Global Market Taxonomy

        2.1.2. Global Market Definition

    2.2. Global Market Size (US$ Mn) and Forecast, 2018-2033

        2.2.1. Global Market Y-o-Y Growth

    2.3. Global Market Dynamics

    2.4. Regulations

    2.5. Supply Chain

    2.6. Cost Structure

    2.7. Average Pricing Analysis

    2.8. Epidemiology

    2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Market Analysis and Forecast By Drug

    3.1. Global Market Size and Forecast By Drug, 2018-2033

        3.1.1. Bivalirudin Market Size and Forecast, 2018-2033

            3.1.1.1. Revenue (US$ Mn) Comparison, By Region

            3.1.1.2. Market Share Comparison, By Region

            3.1.1.3. Y-o-Y growth Comparison, By Region

        3.1.2. Eptifibatide Market Size and Forecast, 2018-2033

            3.1.2.1. Revenue (US$ Mn) Comparison, By Region

            3.1.2.2. Market Share Comparison, By Region

            3.1.2.3. Y-o-Y growth Comparison, By Region

4. Global Market Analysis and Forecast By Distribution Channel

    4.1. Global Market Size and Forecast By Distribution Channel, 2018-2033

        4.1.1. Hospital Pharmacies Market Size and Forecast, 2018-2033

            4.1.1.1. Revenue (US$ Mn) Comparison, By Region

            4.1.1.2. Market Share Comparison, By Region

            4.1.1.3. Y-o-Y growth Comparison, By Region

        4.1.2. Retail Pharmacies Market Size and Forecast, 2018-2033

            4.1.2.1. Revenue (US$ Mn) Comparison, By Region

            4.1.2.2. Market Share Comparison, By Region

            4.1.2.3. Y-o-Y growth Comparison, By Region

        4.1.3. Online Pharmacies Market Size and Forecast, 2018-2033

            4.1.3.1. Revenue (US$ Mn) Comparison, By Region

            4.1.3.2. Market Share Comparison, By Region

            4.1.3.3. Y-o-Y growth Comparison, By Region

5. Global Market Analysis and Forecast By Region

    5.1. Global Market Size and Forecast, 2018-2033

        5.1.1. North America Market Size and Forecast, 2018-2033

            5.1.1.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

        5.1.2. Latin America Market Size and Forecast, 2018-2033

            5.1.2.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

        5.1.3. Europe Market Size and Forecast, 2018-2033

            5.1.3.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

        5.1.4. Japan Market Size and Forecast, 2018-2033

            5.1.4.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

        5.1.5. APEJ Market Size and Forecast, 2018-2033

            5.1.5.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel

        5.1.6. MEA Market Size and Forecast, 2018-2033

            5.1.6.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel

6. North America Market Analysis and Forecast, By Country, 2018-2033

    6.1. US Market Size and Forecast, 2018-2033

        6.1.1. Revenue (US$ Mn) Comparison, By Drug

        6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    6.2. Canada Market Size and Forecast, 2018-2033

        6.2.1. Revenue (US$ Mn) Comparison, By Drug

        6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

7. Latin America Market Analysis and Forecast, By Country, 2018-2033

    7.1. Brazil Market Size and Forecast, 2018-2033

        7.1.1. Revenue (US$ Mn) Comparison, By Drug

        7.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    7.2. Mexico Market Size and Forecast, 2018-2033

        7.2.1. Revenue (US$ Mn) Comparison, By Drug

        7.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    7.3. Argentina Market Size and Forecast, 2018-2033

        7.3.1. Revenue (US$ Mn) Comparison, By Drug

        7.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

8. Europe Market Analysis and Forecast, By Country, 2018-2033

    8.1. Germany Market Size and Forecast, 2018-2033

        8.1.1. Revenue (US$ Mn) Comparison, By Drug

        8.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.2. UK Market Size and Forecast, 2018-2033

        8.2.1. Revenue (US$ Mn) Comparison, By Drug

        8.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.3. France Market Size and Forecast, 2018-2033

        8.3.1. Revenue (US$ Mn) Comparison, By Drug

        8.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.4. Spain Market Size and Forecast, 2018-2033

        8.4.1. Revenue (US$ Mn) Comparison, By Drug

        8.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.5. Italy Market Size and Forecast, 2018-2033

        8.5.1. Revenue (US$ Mn) Comparison, By Drug

        8.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.6. Nordic Market Size and Forecast, 2018-2033

        8.6.1. Revenue (US$ Mn) Comparison, By Drug

        8.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel

9. Japan Market Analysis and Forecast, By Country, 2018-2033

    9.1. Japan Market Size and Forecast, 2018-2033

        9.1.1. Revenue (US$ Mn) Comparison, By Drug

        9.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

10. APEJ Market Analysis and Forecast, By Country, 2018-2033

    10.1. China Market Size and Forecast, 2018-2033

        10.1.1. Revenue (US$ Mn) Comparison, By Drug

        10.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.2. India Market Size and Forecast, 2018-2033

        10.2.1. Revenue (US$ Mn) Comparison, By Drug

        10.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.3. Malaysia Market Size and Forecast, 2018-2033

        10.3.1. Revenue (US$ Mn) Comparison, By Drug

        10.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.4. Thailand Market Size and Forecast, 2018-2033

        10.4.1. Revenue (US$ Mn) Comparison, By Drug

        10.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.5. Singapore Market Size and Forecast, 2018-2033

        10.5.1. Revenue (US$ Mn) Comparison, By Drug

        10.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.6. Australia Market Size and Forecast, 2018-2033

        10.6.1. Revenue (US$ Mn) Comparison, By Drug

        10.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel

11. MEA Market Analysis and Forecast, By Country, 2018-2033

    11.1. GCC Countries Market Size and Forecast, 2018-2033

        11.1.1. Revenue (US$ Mn) Comparison, By Drug

        11.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    11.2. South Africa Market Size and Forecast, 2018-2033

        11.2.1. Revenue (US$ Mn) Comparison, By Drug

        11.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    11.3. Nigeria Market Size and Forecast, 2018-2033

        11.3.1. Revenue (US$ Mn) Comparison, By Drug

        11.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    11.4. Israel Market Size and Forecast, 2018-2033

        11.4.1. Revenue (US$ Mn) Comparison, By Drug

        11.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

12. Global Market Competition Landscape and Company Profile

    12.1. Company Share Analysis By Region

        12.1.1. AstraZeneca plc

            12.1.1.1. Company Overview

            12.1.1.2. Market Drug list

            12.1.1.3. Market Drug Sales Data and Key Financials

            12.1.1.4. Key Developments

            12.1.1.5. SWOT Analysis

        12.1.2. CordenPharma International

            12.1.2.1. Company Overview

            12.1.2.2. Market Drug list

            12.1.2.3. Market Drug Sales Data and Key Financials

            12.1.2.4. Key Developments

            12.1.2.5. SWOT Analysis

        12.1.3. Ipsen S.A

            12.1.3.1. Company Overview

            12.1.3.2. Market Drug list

            12.1.3.3. Market Drug Sales Data and Key Financials

            12.1.3.4. Key Developments

            12.1.3.5. SWOT Analysis

        12.1.4. Merck & Co., Inc

            12.1.4.1. Company Overview

            12.1.4.2. Market Drug list

            12.1.4.3. Market Drug Sales Data and Key Financials

            12.1.4.4. Key Developments

            12.1.4.5. SWOT Analysis

        12.1.5. Pfizer Inc.

            12.1.5.1. Company Overview

            12.1.5.2. Market Drug list

            12.1.5.3. Market Drug Sales Data and Key Financials

            12.1.5.4. Key Developments

            12.1.5.5. SWOT Analysis

        12.1.6. Apotex Holdings, Inc.

            12.1.6.1. Company Overview

            12.1.6.2. Market Drug list

            12.1.6.3. Market Drug Sales Data and Key Financials

            12.1.6.4. Key Developments

            12.1.6.5. SWOT Analysis

        12.1.7. Dr. Reddy’s Laboratories Limited

            12.1.7.1. Company Overview

            12.1.7.2. Market Drug list

            12.1.7.3. Market Drug Sales Data and Key Financials

            12.1.7.4. Key Developments

            12.1.7.5. SWOT Analysis

        12.1.8. Fresenius Kabi USA, LLC

            12.1.8.1. Company Overview

            12.1.8.2. Market Drug list

            12.1.8.3. Market Drug Sales Data and Key Financials

            12.1.8.4. Key Developments

            12.1.8.5. SWOT Analysis

        12.1.9. Novetide Ltd

            12.1.9.1. Company Overview

            12.1.9.2. Market Drug list

            12.1.9.3. Market Drug Sales Data and Key Financials

            12.1.9.4. Key Developments

            12.1.9.5. SWOT Analysis

        12.1.10. Amneal Pharmaceuticals LLC

            12.1.10.1. Company Overview

            12.1.10.2. Market Drug list

            12.1.10.3. Market Drug Sales Data and Key Financials

            12.1.10.4. Key Developments

            12.1.10.5. SWOT Analysis

13. Research Methodology

14. Secondary and Primary Sources

15. Assumptions and Acronyms

16. Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ペプチドベース心臓血管治療薬の世界市場2023年-2033年：予測・動向・分析・競争状況(Peptide-based Cardiovascular Therapeutics Market By Drug (Bivalirudin, Eptifibatide), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Region – Global Market Insights 2023 to 2033)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ペプチド感染症治療薬の世界市場2023年～2033年：予測・動向・分析・競争状況
  • ペプチド治療薬（メタボリックシンドローム用）の世界市場2023年～2033年：予測・動向・分析・競争状況
  • 細胞株開発の世界市場2023年-2033年：予測・動向・分析・競争状況
  • 小児医療用OTC医薬品の世界市場2023年-2033年：予測・動向・分析・競争状況
  • プレフィルドオートインジェクター（薬剤充填済み自動注射器）の世界市場2023年～2033年：予測・動向・分析・競争状況

    • ◆H&Iグローバルリサーチのお客様（例）◆